Stock Earnings

Question 1

What are Niagen Bioscience Inc's key financial statements?

Accepted Answer

According to the latest financial statement (Form-10K), Niagen Bioscience Inc has a total asset of $68, Net profit of $8

Question 2

What are the key financial ratios for NAGE?

Accepted Answer

Niagen Bioscience Inc's Current ratio is 3.09, has a Net margin is 8.08, sales per share of $1.26.

Question 3

How is Niagen Bioscience Inc's revenue broken down by segment or geography?

Accepted Answer

Currently Niagen Bioscience Inc data is not available.

Question 4

Is Niagen Bioscience Inc profitable?

Accepted Answer

yes, according to the latest financial statements, Niagen Bioscience Inc has a net profit of $8

Question 5

Does Niagen Bioscience Inc have any liabilities?

Accepted Answer

yes, Niagen Bioscience Inc has liability of 22

Question 6

How many outstanding shares for Niagen Bioscience Inc?

Accepted Answer

Niagen Bioscience Inc has a total outstanding shares of 77.33

Breakdown	TTM	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020
Revenue	124	99	83	72	67	59
Revenue Growth (YoY)	36%	19%	15%	7%	14%	28%
Cost of Revenue	45	38	32	29	25	23
Gross Profit	79	61	50	42	41	35
Selling, General & Admin	54	47	51	56	64	51
Research & Development	5	6	4	4	3	3
Operating Expenses	60	53	56	61	68	55
Other Non Operating Income (Expenses)	--	--	0	2	--	--
Pretax Income	21	8	-4	-16	-27	-19
Income Tax Expense	0	0	--	--	--	--
Net Income	20	8	-4	-16	-27	-19
Net Income Growth	1,900%	-300%	-75%	-41%	42%	-41%
Shares Outstanding (Diluted)	86.61	78.12	74.98	69.73	67.19	61.07
Shares Change (YoY)	11%	4%	8%	4%	10%	7%
EPS (Diluted)	0.24	0.1	-0.06	-0.24	-0.4	-0.33
EPS Growth	1,186%	-266%	-73%	-40%	21%	-41%
Free Cash Flow	21	11	6	-15	-24	-10
Free Cash Flow Per Share	0.24	0.14	0.08	-0.21	-0.35	-0.16
Gross Margin	63.7%	61.61%	60.24%	58.33%	61.19%	59.32%
Operating Margin	15.32%	7.07%	-6.02%	-25%	-40.29%	-32.2%
Profit Margin	16.12%	8.08%	-4.81%	-22.22%	-40.29%	-32.2%
Free Cash Flow Margin	16.93%	11.11%	7.22%	-20.83%	-35.82%	-16.94%
EBITDA	19	7	-4	-17	-26	-18
EBITDA Margin	15.32%	7.07%	-4.81%	-23.61%	-38.8%	-30.5%
D&A For EBITDA	0	0	1	1	1	1
EBIT	19	7	-5	-18	-27	-19
EBIT Margin	15.32%	7.07%	-6.02%	-25%	-40.29%	-32.2%
Effective Tax Rate	0%	0%	--	--	--	--

Niagen Bioscience Inc (NAGE) Price